-
Targeted Gene Panel for 171 PTCLs
Study
EGAS00001002740
-
We describe a method to culture organoids from adult human kidney tissue and describe applications for the culture system.
Study
EGAS00001002729
-
A somatic reference standard for cancer genome sequencing with COLO829
Study
EGAS00001001385
-
Comprehensive genomic profiling of matched glioblastoma tumours, cell-lines, and xenografts reveals genomic stability and adaptation to disparate growth environments
Study
EGAS00001002709
-
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
Study
EGAS00001004544
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__Oesophageal_squamous_cell_carcinoma
Study
EGAS00001002725
-
Glioblastoma_CRISPR_Screen
Study
EGAS00001001519
-
Detection of clinically relevant genetic and transcriptomic landscape in DLBCL uniformly treated by R-CHOP
Study
EGAS00001002657
-
Mutational spectrum of highly differentiated, fusion-negative rhabdomyosarcoma (set 2).
Study
EGAS00001002771
-
Whole genome sequencing of Ewings Sarcoma
Study
EGAS00001003385
-
A comprehensive assessment of somatic mutation detection in cancer using whole genome sequencing
Study
EGAS00001001539
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__pancreas
Study
EGAS00001002726
-
PSCP_mutation_analysis_in_hESCs
Study
EGAS00001001561
-
We performed whole-exome sequencing of 20 samples (10 actinic keratosis and 10 cutaneous squamous cell carcinoma) to investigate a potential relationship between DNA methylation-based subtypes and genetic mutation patterns (Rodriguez-Paredes et al., Nat Commun 2017)
Study
EGAS00001002670
-
Whole genome sequencing of primary and metastatic Melanoma cases in an Australian cohort.
Study
EGAS00001001552
-
Single cell transcriptomic and genomic profiling of carcinogenesis in patients with familial adenomatous polyposis
Study
EGAS00001003598
-
Integrated genomic characterization of IDH1 mutant Glioma malignant progression
Study
EGAS00001001588
-
Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients
Study
EGAS00001003255
-
Malignant pheochromocytomas/paragangliomas harbor mutations in transport and cell adhesion genes
Study
EGAS00001001601
-
A genomic approach towards an understanding of clonal evolution and disease progression in multiple myeloma
Study
EGAS00001002850
-
2014_Lung_sq_WES
Study
EGAS00001002844
-
Whole exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma
Study
EGAS00001002705
-
Aggressive genomic features in clinicallyindolent primary HHV8-negative effusion-based lymphoma
Study
EGAS00001002743
-
Exome sequencing of advanced hepatocellular carcinoma
Study
EGAS00001003130
-
Whole exome sequencing of small cell neuroendocrine cancer of the cervix
Study
EGAS00001003142
-
BLUEPRINT DNA Methylation 450K data of mantle cell lymphoma
Study
EGAS00001001637
-
Spatial and Temporal Homogeneity of Driver Mutations in Diffuse Intrinsic Pointine Glioma
Study
EGAS00001001654
-
Identifying_Novel_Fusion_Genes_in_Myeloma
Study
EGAS00001000220
-
Colorectal adenomas and carcinomas NKI-AvL TGO series Gut2009
Study
EGAS00001002758
-
UAMS Smoldering Myeloma Myeloma Sequencing
Study
EGAS00001003629
-
Integrative multi-omic analyses of malignant pleural mesothelioma
Study
EGAS00001004812
-
Single-cell RNA sequencing on 5063 single T cells isolated from peripheral blood, tumour and adjacent normal tissues from six hepatocellular carcinoma patients.
Study
EGAS00001002072
-
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Study
EGAS00001003306
-
Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T-cell lymphomas with hemophagocytic lymphohistiocytic syndrome
Study
EGAS00001002765
-
An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors
Study
EGAS00001002786
-
Somatic IL4R Hotspot Mutations in Primary Mediastinal Large B-cell lymphoma lead to constitutive JAK-STAT activation
Study
EGAS00001002796
-
Adeno-associated virus in the liver: natural history and consequences in tumor development
Study
EGAS00001003310
-
Evolutionary Genome Analysis of Transformation into Small Cell Carcinomas from Lung Adenocarcinomas
Study
EGAS00001001757
-
HYPERMUTATION AND MALIGNANT PROGRESSION IN LOW-GRADE GLIOMA PATIENTS
Study
EGAS00001002368
-
Genomic analysis Nasopharyngeal cancer through whole exome sequencing and whole genomic sequencing.
Study
EGAS00001002788
-
Genetic landscape of pediatric Adrenocortical Tumor
Study
EGAS00001000257
-
Genomic profiling of matched well differentiated and de-differentiated liposarcoma.
Study
EGAS00001002807
-
Evolution of GBM through therapy
Study
EGAS00001003546
-
ChIP Seq data of multiple myeloma and plasma cell leukaemia cell lines
Study
EGAS00001002414
-
Pilot study for Illumina TST170 NGS panel on cutaneous T cell lymphoma samples
Study
EGAS00001002567
-
Analysis of tumor periphery and center-specific mutations in renal cell carcinoma
Study
EGAS00001001784
-
Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis
Study
EGAS00001001788
-
RRBS MDACC Lung PreCancer
Study
EGAS00001004610
-
Targeted exome sequencing of pleomorphic invasive lobular carcinoma (PILC).
Study
EGAS00001002871
-
Combined targeting of BRD4-associated Promoter Activation and NFKB Immunomodulation in ARID1A-mutated Gastric Adenocarcinoma
Study
EGAS00001006397
-
Foundation Medicine Genomic Data Used to Identify Prognostic Markers and Fusion Genes in Multiple Myeloma
Study
EGAS00001002874
-
Recapitulation of genetic predisposition to medulloblastoma in human neuroepithelial stem cells
Study
EGAS00001003620
-
Single cell RNA sequencing of lung adenocarcinoma.
Study
EGAS00001003681
-
Robust detection of translocations in lymphoma FFPE samples using Targeted Locus Capture-based sequencing - NGS targeted capture control cohort
Study
EGAS00001005325
-
MGA-NUTM1 fusion in high grade spindle cell sarcoma
Study
EGAS00001003341
-
WGS and WES of pediatric osteosarcoma
Study
EGAS00001003342
-
A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma
Study
EGAS00001001805
-
Genomic Heterogeneity and the Small Renal Mass
Study
EGAS00001002919
-
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
Study
EGAS00001002928
-
RNAseq of 76 samples from Uveal Melanoma tumors
Study
EGAS00001002932
-
Mutational Patterns in Metastatic Cutaneous Squamous Cell Carcinoma
Study
EGAS00001003370
-
Cancer and germline exomes consisting of FASTQ paired-end reads from melanoma and lung cancer samples
Study
EGAS00001003723
-
Single cell copy number and chromatin accessibility in primary multiple myeloma cells
Study
EGAS00001005382
-
Integrated Genomic, Epigenetic, and Expression Analyses of Ovarian Cancer Cell Lines
Study
EGAS00001002998
-
Biallelic tumor suppressor loss and DNA repair defects in de novo small cell prostate cancer
Study
EGAS00001003007
-
DNA Methylation loss coupled with mitotic cell division promotes immune evasion of tumours with high mutation load
Study
EGAS00001003731
-
CCND1-negative MCL
Study
EGAS00001003060
-
Ewings Sarcoma RNA-Seq
Study
EGAS00001003062
-
Whole Exome Sequencing of 60 tumor/normal matched liver Cancers (HCC)
Study
EGAS00001003063
-
Tissue and plasma RNA from esophageal cancer and precursor lesions
Study
EGAS00001004939
-
Feasibility Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab (OpACIN) in resectable stage III melanoma patients
Study
EGAS00001003099
-
Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas
Study
EGAS00001003430
-
DERMATLAS__Myopericytoma
Study
EGAS00001006676
-
whole-genome sequencing in 17 ESCC cases and whole-exome sequencing in 71 cases
Study
EGAS00001000709
-
Targeted_sequencing_of_cylindroma_patients
Study
EGAS00001002708
-
Biomarker Screen for Efficacy of Oncolytic Virotherapy in Patient-derived Pancreatic Cancer Cultures
Study
EGAS00001007001
-
MutWP1__CRUK_Grand_Challenge__matched_blood_Nanoseq
Study
EGAS00001006774
-
CAF-S3 subset in human breast and ovarian cancers
Study
EGAS00001003344
-
Gene expression profile of mesothelial-derived carcinoma-associated fibroblasts
Study
EGAS00001003747
-
NRG1 Fusions in KRAS Wild-type Pancreatic Cancer (H021)
Study
EGAS00001002759
-
WES of melanoma tumors treated with combined immune checkpoint blockade
Study
EGAS00001003857
-
Identification of rare germline variants in familial multiple myeloma
Study
EGAS00001004734
-
DIPG RNA and exome sequencing
Study
EGAS00001004749
-
Subtype specific progression from DCIS to invasive breast cancer
Study
EGAS00001001866
-
Exome sequencing of a novel cervical cancer cell line
Study
EGAS00001003343
-
Targeted panel data for newly diagnosed myeloma patients.
Study
EGAS00001002859
-
Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis -Part II
Study
EGAS00001003357
-
Normal brain controls for ICGC PedBrain DNA methylation sequencing
Study
EGAS00001000909
-
Growth Hormone (GH) -secreting Pituitary Adenoma
Study
EGAS00001003488
-
Alveolar Rhabdomyosarcoma case report
Study
EGAS00001004828
-
The_contribution_of_POT1_variants_to_sporadic_melanoma_development
Study
EGAS00001001964
-
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma (H033)
Study
EGAS00001003481
-
Immune trajectory of response and adverse effect in immunotherapy-treated hepatocellular carcinoma
Study
EGAS00001004843
-
Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma
Study
EGAS00001004550
-
Whole genome and whole transcriptome sequencing of Hepatosplenic T Cell Lymphoma tumor.
Study
EGAS00001003775
-
Tumor-derived cell lines as pharmacogenomic models to predict therapeutic vulnerabilities in hepatocellular carcinoma
Study
EGAS00001003536
-
RNA-seq of Ewing sarcoma tumors (ICGC)
Study
EGAS00001003333
-
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma
Study
EGAS00001003564
-
Sequencing_melanoma_germlines
Study
EGAS00001002081
-
Mutational analysis of an oligoprogressive sarcomatoid hepatocellular carcinoma treated with an immune checkpoint inhibitor.
Study
EGAS00001005064